You've probably heard about rising healthcare costs, especially for prescription drugs. But did you know a major pharmaceutical company just struck a deal with the White House that could change how some of these life-saving medicines are priced?
Regeneron is trending because they just made a landmark drug pricing agreement with the White House.
This deal, announced in late 2023, is for their blockbuster drug Eylea, used to treat serious eye conditions.